has tirzepatide been fda approved approval for Zepbound: FSU researcher available for context on newly weight loss treatment Tirzepatide for Weight Loss |

Before each injection, inspect the medication visuallytirzepatide should be clear and colorless to slightly yellow

Ozempic causes weight loss primarily by reducing appetite and increasing feelings of fullness through its action on GLP-1 receptors in the brain, leading to decreased caloric intake rather than increased energy expenditure

Symptoms may also appear after increasing the dosage because the digestive system must adjust again

Resources and Next Steps Professional Organizations Academy of Nutrition and Dietetics Pediatric Nutrition Practice Group The Obesity Society Pediatric Obesity Section American Academy of Pediatrics Obesity guidelines and resources Pediatric Endocrine Society GLP-1 position statements Key Research and Guidelines AAP Clinical Practice Guideline for Obesity (2023) Pediatrics: GLP-1 Receptor Agonists in Pediatric and Adolescent Obesity (2025) NEJM: Semaglutide in Adolescents with Obesity (2022) CMAJ: Canadian Pediatric Obesity Guidelines Continuing Education Opportunities CDR Certificate of Training in Obesity for Pediatrics and Adults Board Certification in Pediatric Nutrition (CSP) Board Certification in Obesity and Weight Management (CSOWM) University-based certificate programs in pediatric weight management Stay Current Set up PubMed alerts for GLP-1 AND pediatric Follow pediatric endocrinologists on social media Join the Pediatric Nutrition Practice Group listserv Attend ObesityWeek for the latest research Your Next Steps Assess Your Current Knowledge: Take stock of what you know about GLP-1 medications and identify any knowledge gaps.s Choose Initial Training: Begin with free resources, such as podcasts and webinars